Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
1(9%)
Results Posted
83%(5 trials)
Terminated
1(9%)

Phase Distribution

Ph phase_3
5
45%
Ph phase_2
4
36%
Ph phase_4
2
18%

Phase Distribution

0

Early Stage

4

Mid Stage

7

Late Stage

Phase Distribution11 total trials
Phase 2Efficacy & side effects
4(36.4%)
Phase 3Large-scale testing
5(45.5%)
Phase 4Post-market surveillance
2(18.2%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

11

all time

Status Distribution
Active(3)
Completed(6)
Terminated(1)
Other(1)

Detailed Status

Completed6
Not yet recruiting2
unknown1
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
1
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 24 (36.4%)
Phase 35 (45.5%)
Phase 42 (18.2%)

Trials by Status

not_yet_recruiting218%
completed655%
unknown19%
terminated19%
recruiting19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
DRUG
Total Trials
11